Results 161 to 170 of about 249,684 (338)
This study identifies alnustone, a natural compound from Alpinia katsumadai, as a potent therapeutic agent for MASLD and MASH. Alnustone enhances mitochondrial fatty acid β‐oxidation by directly targeting calmodulin, improving liver steatosis, fibrosis, and insulin resistance in vivo.
Shourui Hu+13 more
wiley +1 more source
Preliminary clinical report of proton therapy at hyogo ion beam medical center (HIBMC) [PDF]
Masao Murakami+7 more
openalex +1 more source
CTSK plays a critical role in pulmonary fibrosis. Excessive CTSK accumulation interacts with SNX9 to enhance TGF‐β1‐induced SMAD3 activation and GLS1 expression in fibroblasts, driving glutamine metabolism for collagen biosynthesis and exacerbating pulmonary fibrosis.
Mengting Chen+10 more
wiley +1 more source
Modeling and Validation of a Proton Therapy Couch Top. [PDF]
Batin E, Faught A, Lee H, Ayan A.
europepmc +1 more source
Genetics‐Based Targeting Strategies for Precise Neuromodulation
In this Review, the fundamental principles and implementation protocols of genetics‐based precision neuromodulation are first introduced. Then, wireless and low‐invasive strategies based on nano‐transducing materials are highlighted, along with a dissection and analysis of the strengths and weaknesses of representative studies.
Yuyuan He+11 more
wiley +1 more source
Bridging the proton gap: A proton therapy consultation service for Canadian radiation oncologists. [PDF]
Kim I+10 more
europepmc +1 more source
Eye-preserving proton radiation therapy (PRT) for medium and large choroidal melanoma
M. Fuß+3 more
openalex +1 more source
A non-resonant RF cavity loaded with amorphous alloy for proton cancer therapy [PDF]
Yoshimasa Makita+5 more
openalex +1 more source
Dynein‐Dependent Endo‐Lysosomal Degradation Drives Lewy Body Disorders Accompanied by Aβ Pathology
This study investigates the impact of Aβ plaques on α‐synuclein (αSyn) pathologies in dementia with Lewy bodies (DLB). Co‐culturing primary neurons with AD mouse brain slices reveals impaired dynein‐dependent organelle trafficking, affecting αSyn degradation. Activating Rab7 restores this process, reducing αSyn inclusions.
Linlin Zhou+14 more
wiley +1 more source